Characterization and Trypanocidal Activity of a Novel Pyranaphthoquinone
Authors:
- Elen Diana DantasEDElen Diana Dantas
- Fabia Julliana Jorge De SouzaFSFabia Julliana Jorge De Souza
- William Nascimento Litaiff NogueiraWNWilliam Nascimento Litaiff Nogueira
- Cláudia Cândida SilvaCSCláudia Cândida Silva
- Pedro Henrique Antunes De AzevedoPAPedro Henrique Antunes De Azevedo
- Cícero Flávio Soares AragãoCícero Flávio Soares Aragão
- Patricia Danielle Oliveira de AlmeidaPAPatricia Danielle Oliveira de Almeida
- Mariana Filomena Do Carmo CardosoMCMariana Filomena Do Carmo Cardoso
- Fernando De Carvalho Da SilvaFSFernando De Carvalho Da Silva
- Eduardo Pereira De AzevedoEAEduardo Pereira De Azevedo
- Euzébio Guimarães BarbosaEBEuzébio Guimarães Barbosa
- Emerson Silva LimaELEmerson Silva Lima
Open Access
- 30 September 2017
- Vol. 22 (10) , 1631
Abstract
Chagas disease is an endemic parasitic infection that occurs in 21 Latin American countries. New therapies for this disease are urgently needed, as the only two drugs available (nifurtimox and benznidazol) have high toxicity and variable efficacy in the disease’s chronic phase. Recently, a new chemical entity (NCE) named Pyranaphthoquinone (IVS320) was synthesized from lawsone. We report herein, a detailed study of the physicochemical properties and in vitro trypanocidal activity of IVS320. A series of assays were performed for characterization, where thermal, diffractometric, and morphological analysis were performed. In addition, the solubility, permeability, and hygroscopicity of IVS320 were determined. The results show that its poor solubility and low permeability may be due to its high degree of crystallinity (99.19%), which might require the use of proper techniques to increase the IVS320’s aqueous solubility and permeability. The trypanocidal activity study demonstrated that IVS320 is more potent than the reference drug benznidazole, with IC50/24 h of 1.49 ± 0.1 μM, which indicates that IVS320 has potential as a new drug candidate for the treatment of Chagas disease.Keywords
This publication has 38 references indexed in Scilit:
- Molecular identification of clinical “difficult-to-identify” microbes from sequencing 16S ribosomal DNA and internal transcribed spacer 2Annals of Clinical Microbiology and Antimicrobials, 2014
- On the search for potential anti-Trypanosoma cruzi drugs: Synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactionsEuropean Journal of Medicinal Chemistry, 2012
- Beyond Size, Ionization State, and Lipophilicity: Influence of Molecular Topology on Absorption, Distribution, Metabolism, Excretion, and Toxicity for Druglike CompoundsJournal of Medicinal Chemistry, 2012
- Efficient throughput method for hygroscopicity classification of active and inactive pharmaceutical ingredients by water vapor sorption analysisPharmaceutical Development and Technology, 2011
- The Solubility–Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to ProgesteroneJournal of Pharmaceutical Sciences, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Crystal structure of Trypanosoma cruzi pteridine reductase 2 in complex with a substrate and an inhibitorJournal of Structural Biology, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Structure and function of a novel purine specific nucleoside hydrolase from Trypanosoma vivax11Edited by R. HuberJournal of Molecular Biology, 2001
- The Protein Data BankNucleic Acids Research, 2000